Argatroban
Who holds supplier records for Argatroban? 8 organisations hold a current record for Argatroban: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: Italy (2), India (2), China (1) and France (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Argatroban: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/argatroban
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Argatroban. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CURIA ITALY SRLItaly Company GMP cert on recordActive DMF 20760, 40227 · latest filing Aug 2024
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 25400, 28030 · latest filing May 2014
- ALP PHARM BEIJING CO LTDActive DMF 25893 · latest filing Feb 2012
- BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTDChinaActive DMF 35491 · latest filing Dec 2020
- CHEMWERTH INCFranceActive DMF 20709 · latest filing Jul 2007
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 25765 · latest filing Mar 2012
- LUNDBECK PHARMACEUTICALS ITALY SPAItaly Company GMP cert on recordActive DMF 21304 · latest filing Jan 2008
- SUZHOU RYWAY BIOTECH CO LTDActive DMF 42426 · latest filing Aug 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Argatroban are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- Taiwan · Inactive DMF 22935 · filed Jul 2009
Overview
Argatroban is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1166).
Chemical identity
- IUPAC name
- (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid
- Canonical SMILES
- C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C
- InChIKey
- KXNPVXPOPUZYGB-IOVMHBDKSA-N
- Synonyms
- Acova, Argatroban, Argatroban anhydrous, Argatroban hydrate, Argatroban in dextrose, Argatroban in sodium chloride, Argatroban monohydrate, Argipidine, DK-7419, GN-1600, GN1600, MCI-9038
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Anti-coagulant; Direct Thrombin Inhibitor
- Mechanism of action
- Thrombin Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Argatroban?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Argatroban: CURIA ITALY SRL (Italy), GLAND PHARMA LTD (India), ALP PHARM BEIJING CO LTD, BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD (China), CHEMWERTH INC (France), Emcure Pharmaceuticals Limited (India), LUNDBECK PHARMACEUTICALS ITALY SPA (Italy) and SUZHOU RYWAY BIOTECH CO LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Argatroban Drug Master Files are active?
CURIA ITALY SRL (DMF 20760, 40227), GLAND PHARMA LTD (DMF 25400, 28030), ALP PHARM BEIJING CO LTD (DMF 25893), BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD (DMF 35491), CHEMWERTH INC (DMF 20709), Emcure Pharmaceuticals Limited (DMF 25765), LUNDBECK PHARMACEUTICALS ITALY SPA (DMF 21304) and SUZHOU RYWAY BIOTECH CO LTD (DMF 42426). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Argatroban records mean?
1 organisation has only inactive Type II DMFs for Argatroban. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Argatroban supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Argatroban?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.